Methyldopa

Hypertension, Hypertensive disease, Therapeutic procedure

Treatment

1 FDA approval

20 Active Studies for Methyldopa

What is Methyldopa

Methyldopa

The Generic name of this drug

Treatment Summary

Methyldopa is a drug used to lower blood pressure. It is an analog of DOPA and needs to be converted into an active form in order to have an effect on the body. It works by binding to alpha-2 adrenergic receptors, which helps lower the activity of the nerves that control blood vessel constriction. First approved in 1960, it is still used to treat hypertension, although newer drugs are available that are better tolerated. Methyldopa is sometimes given as an intravenous injection when oral therapy is not possible or to manage a hypertensive crisis.

Aldoril

is the brand name

image of different drug pills on a surface

Methyldopa Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Aldoril

Methyldopa

1962

32

Approved as Treatment by the FDA

Methyldopa, otherwise known as Aldoril, is approved by the FDA for 1 uses like Hypertensive disease .

Hypertensive disease

Helps manage High Blood Pressure (Hypertension)

Effectiveness

How Methyldopa Affects Patients

Methyldopa helps to lower blood pressure by targeting the body’s sympathetic nervous system and reducing the concentrations of certain hormones. It usually begins to work within 12 to 24 hours, and the maximum effect on blood pressure can be seen in 4 to 6 hours. The effects wear off after 24 to 48 hours when the drug is stopped. When taken intravenously, the effects can last for 10 to 16 hours.

How Methyldopa works in the body

Methyldopa works by blocking nerve signals that cause blood vessels to constrict. It is metabolized into two active compounds that bind to receptors in the brainstem, which in turn reduces the output of signals to the peripheral nervous system. This creates a calming, vasodilator effect, which lowers the blood pressure. Methyldopa also blocks an enzyme called DOPA decarboxylase, which helps make neurotransmitters like norepinephrine, but this plays only a small role in lowering blood pressure.

When to interrupt dosage

The recommended measure of Methyldopa is contingent upon the diagnosed condition, including Therapeutic procedure, Hypertensive crisis and Hypertensive disease. The amount of dosage also is dependent upon the mode of delivery (e.g. Intravenous or Tablet, film coated - Oral) identified in the table beneath.

Condition

Dosage

Administration

Hypertension

250.0 mg, , 500.0 mg, 50.0 mg/mL, 125.0 mg, 250.0 mg/mL

Oral, Tablet, film coated, Tablet, film coated - Oral, , Tablet, Tablet - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Liquid - Intravenous, Liquid

Hypertensive disease

250.0 mg, , 500.0 mg, 50.0 mg/mL, 125.0 mg, 250.0 mg/mL

Oral, Tablet, film coated, Tablet, film coated - Oral, , Tablet, Tablet - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Liquid - Intravenous, Liquid

Therapeutic procedure

250.0 mg, , 500.0 mg, 50.0 mg/mL, 125.0 mg, 250.0 mg/mL

Oral, Tablet, film coated, Tablet, film coated - Oral, , Tablet, Tablet - Oral, Intravenous, Injection, solution - Intravenous, Injection, solution, Liquid - Intravenous, Liquid

Warnings

Methyldopa Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

history of liver disorders caused by methyldopa

Do Not Combine

Liver Diseases

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Methyldopa may interact with Pulse Frequency

There are 20 known major drug interactions with Methyldopa.

Common Methyldopa Drug Interactions

Drug Name

Risk Level

Description

Amifostine

Major

Methyldopa may increase the hypotensive activities of Amifostine.

Iobenguane

Major

The therapeutic efficacy of Iobenguane can be decreased when used in combination with Methyldopa.

Abacavir

Minor

Methyldopa may decrease the excretion rate of Abacavir which could result in a higher serum level.

Aclidinium

Minor

Methyldopa may decrease the excretion rate of Aclidinium which could result in a higher serum level.

Acrivastine

Minor

Methyldopa may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Methyldopa Toxicity & Overdose Risk

The lowest amount of Methyldopa that has been found to be toxic in a female is 44 gm/kg taken intermittently. For rats, the toxic amount is 5000 mg/kg and for mice it's 5300 mg/kg. If someone overdoses on Methyldopa, they may experience low blood pressure, excessive drowsiness, slow heartbeat, dizziness, nausea and vomiting. Treatment for Methyldopa overdose includes gastric lavage or emesis, infusions, and monitoring of blood volume, electrolyte balance, and other body functions. Medications like levarterenol, epinephrine, and

image of a doctor in a lab doing drug, clinical research

Methyldopa Novel Uses: Which Conditions Have a Clinical Trial Featuring Methyldopa?

18 active clinical trials are currently evaluating the potential of Methyldopa to provide a therapeutic intervention, Hypertensive disease relief, and Hypertensive crisis management.

Condition

Clinical Trials

Trial Phases

Hypertension

0 Actively Recruiting

Therapeutic procedure

0 Actively Recruiting

Hypertensive disease

27 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Methyldopa Reviews: What are patients saying about Methyldopa?

5

Patient Review

10/12/2009

Methyldopa for High Blood Pressure

I was originally prescribed 250 mg twice daily, but my doctor increased the dosage to 500mg after three weeks in order to mitigate some of the more severe side effects (such as fainting). I have experienced dry mouth and dizziness at times, but those symptoms usually go away within a few days. I am also trying to conceive, so this medication was a better option for me than diovan. If you are thinking about starting this medication, I recommend talking to your doctor about slowly increasing the dose over time. This has worked well for me and has helped keep my blood pressure under control.

5

Patient Review

10/14/2009

Methyldopa for High Blood Pressure

Methyldopa has been a great switch for me. I was originally taking Micardis, but I didn't like it very much. Methyldopa has had no negative side effects that I've noticed and my blood pressure has been excellent since starting this medication.

4.7

Patient Review

6/4/2014

Methyldopa for High Blood Pressure

I was really lucky and didn't experience any negative side effects, except for my blood pressure going down. My nephrologist had me start taking it during my first pregnancy, and I took it for a few months after while trying to get pregnant again. So far so good!

3.7

Patient Review

10/12/2009

Methyldopa for High Blood Pressure

3.3

Patient Review

1/25/2016

Methyldopa for High Blood Pressure

I've been taking this medication for almost four years now, originally starting when I became pregnant. It's done a great job of managing my blood pressure, even during pregnancy. However, the only downside is that I feel constantly tired and fatigued.

3

Patient Review

7/25/2018

Methyldopa for High Blood Pressure

I sweat excessively and feel incredibly sluggish when I even try to walk a short distance.

2.7

Patient Review

2/5/2011

Methyldopa for High Blood Pressure

I began this medication when I became pregnant and was diagnosed with high blood pressure. The dosage was increased over time, but I still lost the baby. I'm wondering if there's a correlation here.

2

Patient Review

9/8/2011

Methyldopa for High Blood Pressure

I had a litany of terrible side effects while taking this medication, which did not effectively control my blood pressure. I spent more time in the hospital than at home while on this medicine, and would not recommend it to anyone.

2

Patient Review

5/7/2019

Methyldopa for High Blood Pressure

Unfortunately, this medication has caused more pain in my left side and chest tightness. I'm not sure what the next step should be.

2

Patient Review

4/20/2013

Methyldopa for High Blood Pressure

My feet, ankles, and legs were significantly swollen.

1.7

Patient Review

3/21/2013

Methyldopa for High Blood Pressure

I began this regimen yesterday, 250mg twice daily. I am feeling very ill and exhausted, to the point that I can't keep anything down. The pharmacy said to give it a couple days, but I'm not so sure. We are trying to conceive so they said this is my only route...

1.3

Patient Review

4/28/2010

Methyldopa for High Blood Pressure

I started taking this medication because we are trying to get pregnant and I was told that it would be safe for my baby. After one week of taking it twice a day, my blood pressure had lowered to 110/78 from 174/102. I did feel a little sleepy and dizzy after the first few doses, but those results were worth it to me.

1

Patient Review

11/14/2020

Methyldopa for High Blood Pressure

I've been on this medication for an extended period of time with no change in my condition. I've gradually increased the dosage as prescribed, and still see no difference. This is a total waste of time and money.

1

Patient Review

11/28/2010

Methyldopa for High Blood Pressure

I developed hypertension and was put on this medication. After eight months, the dosage was increased 500mg three times a day. This medicine worked for a while to lower my blood pressure; however, I stopped responding to the medication after a while. I also experienced fatigue, mood changes, and dizziness as side effects which led me to switch medications.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about methyldopa

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the most common side effect of methyldopa?

"upset stomach

The more common side effects of methyldopa include: drowsiness, headaches, lack of energy, and upset stomachs."

Answered by AI

Is methyldopa an alpha blocker?

"Methyldopa works by binding to alpha(α)-2 adrenergic receptors, which leads to the inhibition of adrenergic neuronal outflow and reduction of vasoconstrictor adrenergic signals."

Answered by AI

Is methyldopa a beta blocker?

"2. Over time, alpha-methyldopa will often lower the total peripheral resistance, but the decrease in cardiac output is usually small, both when resting and during exercise. The beta-blockers lower blood pressure, but also lead to a significant decrease in cardiac output and heart rate."

Answered by AI

Why methyldopa is used in pregnancy?

"Methyldopa can help lower blood pressure and prevent pre-eclampsia, which can cause problems like preterm birth, low birth weight, and serious illness for both the mother and baby."

Answered by AI

Clinical Trials for Methyldopa

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.

Waitlist Available
Has No Placebo

U Health (+1 Sites)

Ziad Zoghby, M.D., M.B.A.

Biobeat Technologies Ltd.

Image of University of Alabama at Birmingham in Birmingham, United States.

Dietary Interventions for Hypertension

18+
All Sexes
Birmingham, AL

Natriuretic peptides (NPs) are hormones produced by the heart and play an important role in maintaining cardiovascular health and have favorable metabolic benefits. Low NP levels are associated with an increased likelihood of the development of cardiometabolic diseases like diabetes and hypertension. NP levels are known to be highly heritable, with up to half of the differences in NP levels being explained by genetics. The investigators aim to describe the genetic architecture of NPs by examining the genetic variants associated with NPs, and generate and validate a polygenic score (PGS) for NPs. The investigators will use this NP PGS to examine the association of genetically determined NP levels with cardiometabolic and cardiovascular outcomes. The investigators will conduct a genotype-guided physiological clinical trial that aims to assess the genetic factors affecting NP levels and their impact on blood pressure and NP response to saline infusion, high-salt diet, and low-salt diet. These findings will help support personal medicine approaches to lower the increasing burden of hypertension in the United States.

Waitlist Available
Has No Placebo

University of Alabama at Birmingham

Pankaj Arora, MD, FAHA

Have you considered Methyldopa clinical trials?

We made a collection of clinical trials featuring Methyldopa, we think they might fit your search criteria.
Go to Trials
Image of Wayne Health Mobile Units in Detroit, United States.

Text Message Reminders for High Blood Pressure

18+
All Sexes
Detroit, MI

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).

Recruiting
Has No Placebo

Wayne Health Mobile Units

Steven J Korzeniewski, PhD

Image of University of Alberta in Edmonton, Canada.

Egg White Powder for High Blood Sugar and High Blood Pressure

18 - 70
All Sexes
Edmonton, Canada

Bioactive peptides derived from food proteins show potential for improving human health. One of such promising peptides is namely IRW made from egg white hydrolysate and composed of three peptides. This is a feasibility study to assess the acute effect of IRW in egg white hydrolysate for the management of high sugar and blood pressure. Participants at high risk of type 2 diabetes (T2D) or having T2D will undergo 4 consecutive treatments of 1 day each (randomly), during which they will consume a standardized breakfast with a smoothie containing different protein powders. Each treatment will be separated by a minimum of 1-week. Participants in the healthy control group will undergo 1 treatment only (one day).

Phase 1
Waitlist Available

University of Alberta

Jianping Wu, PhD

Have you considered Methyldopa clinical trials?

We made a collection of clinical trials featuring Methyldopa, we think they might fit your search criteria.
Go to Trials
Image of Tufts University in Boston, United States.

Food as Medicine for Cardiometabolic Health

18+
All Sexes
Boston, MA

Though the Mississippi Delta has a rich agricultural history and some of the nation's most fertile soil, residents have experienced the legacy of slavery and economic exploitation through food insecurity and poverty for generations. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta Growing a Resilient, Enriching, Equitable, Nourishing food System (GREENS) Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Recruiting
Has No Placebo

Tufts University

Christina D Economos, PhD

Image of UT Southwestern Medical Center in Dallas, United States.

Polypill for Cardiomyopathy Prevention in Type 2 Diabetes

18 - 100
All Sexes
Dallas, TX

This study will investigate the utility of a polypill-based strategy for patients with type 2 diabetes mellitus and high risk of heart failure (HF), as assessed via the WATCH-DM risk score. Polypill therapy will consist of empagliflozin 12.5 mg, losartan 25, 50 or 100 mg, and finerenone 10 mg daily. The study duration is 6 months, and participants will be randomized to either polypill therapy or simultaneous prescription of the individual drugs. The primary outcome is change in peak VO2 and adherence to usual care. The investigators hypothesize that the use of a polypill is feasible and improves medication adherence and peak VO2 as compared to those receiving usual care.

Phase 1 & 2
Recruiting

UT Southwestern Medical Center

Ambarish Pandey, MD, MSCS

Have you considered Methyldopa clinical trials?

We made a collection of clinical trials featuring Methyldopa, we think they might fit your search criteria.
Go to Trials